Dr. Demetre Daskalakis on leaving the CDC and calling out RFK Jr.

Dr. Daniel Jernigan, former director of the CDC’s National Center for Emerging and Zoonotic Infectious Diseases, calls the ...
The Manila Times

Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of James Hassard as Executive Vice President, Chief Commercial Officer

Aligos Therapeutics, Inc. ("Aligos”, Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient ...

Kymera Therapeutics Outlines Key 2026 Objectives and Strategy to Advance Industry Leading Portfolio of Oral Immunology Programs

KT-621 BROADEN2 Phase 2b trial in AD ongoing, with data expected by mid-2027 KT-621 BREADTH Phase 2b trial in asthma initiated, with data expected in late-2027 KT-579 Phase 1 HV clinical trial ...
IEEE

MangoLeafXNet: An Explainable Deep Learning Model for Accurate Mango Leaf Disease Classification

Abstract: Addressing the global challenge of ensuring a consistent and abundant supply of fresh fruit, particularly in the context of fruit crops, is hindered by the prevalence of plant diseases.
The Manila Times

Recludix Pharma Announces Dosing of First Subjects in a Phase 1 Study of REX-8756, a Potent and Selective Oral STAT6 Inhibitor, and Achieves Associated $20 Million Mi…

Phase 1 study of REX-8756 is well underway following FDA clearance of the Investigational New Drug (IND) application in ...
EurekAlert!

Label attention meets deep learning: a novel model for ICD-11 automatic classification of Chinese EMRs

BiLSTM, an ICD-11 automatic coding model using MC-BERT and label attention. Experiments on clinical records show 83.86% ...
Harvard Medical School

Researchers Now Understand How a New Class of Antivirals Works

Members of a new class of antivirals are being tested in U.S. clinical trials, and one has gained approval in Japan, but how ...

How An HIV Drug Is Now Helping People With Genetic Diseases

An HIV-derived nucleoside therapy now treats rare genetic diseases by restoring mitochondrial DNA and improving muscle ...

Biomed Industries Advances NA-931 Into Two Global Phase 3 Trials Alone and with Semaglutide and Tirzepatide for Obesity

Biomed Industries to Advance NA-931 Into Two Global Phase 3 Trials as Monotherapy and in Combination With Semaglutide and Tirzepatide for Obesity Advancing NA-931 into two Phase 3 programs as ...
pharmaphorum

Rumour confirmed as Lilly buys Ventyx for $1.2 billion

A report in the Wall Street Journal, citing people familiar with the matter, suggested an announcement of a transaction could ...

Ventus Therapeutics Announces Nomination of VENT-04, a First-in-Class, Oral, Small-Molecule Caspase-4/5 Inhibitor, as a Development Candidate

Ventus Therapeutics, a clinical-stage biopharmaceutical company advancing multiple small-molecule programs for autoimmune, ...
Kauppalehti

Egle Therapeutics Appoints John Celebi as Chief Executive Officer

Mr. Celebi's appointment comes as Egle enhances its clinical development focus on autoimmune diseases, where recent validation of the IL-2 mechanism has created a significant opportunity for ...